Qiagen receives FDA approval for EGFR mutation test

Qiagen Press Release. This is the third CDx test to be approved for EGFR, and it is the second EGFR mutation test for a lung cancer therapeutic released this year (Roche’s COBAS test was released in May as a CDx for erlotinib). Dako’s IHC test was released...

Medicare Punts on Establishing Dx Reimbursement

Medicare Has Stopped Paying Bills For Medical Diagnostic Tests. Patients Will Feel The Effects – Forbes. Centers for Medicare and Medicaid Services (CMS) decided to do away with old code stacking system for test reimbursement, and had a year to come up with a...

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access